**Core tip**: This article reports regional variations of Crohn's disease and ulcerative colitis in the Central region, Western region, and the Eastern region of the Kingdom of Saudi Arabia. Although incidence trend was increasing in all regions, children from the Eastern region presented with a significantly more severe Crohn's disease than those from the Central region and Western region. Regional analysis in other countries may reveal significant variations indicating the need for prospective studies to identify the causes of such variations.

INTRODUCTION
============

Inflammatory bowel disease (IBD) and its main phenotypes, Crohn's disease (CD) and ulcerative colitis (UC), are reported with a globally increasing trend\[[@B1]-[@B4]\]. Incidence variations with the west-east and north-south falling gradients have been observed across the European continent and within individual countries\[[@B5],[@B6]\]. Over the past three decades, developing countries are reporting more cases of pediatric onset IBD, with a few incidence studies emerging from this part of the world\[[@B7]-[@B10]\]. In the Kingdom of Saudi Arabia (KSA), the incidences, time trends, and clinical and laboratory profiles of pediatric IBD have been reported on a national basis\[[@B11]-[@B17]\]. However, in view of the different cultures and environments of the three main regions of KSA \[Central region (CR), Western region (WR), and Eastern region (ER)\], we hypothesize that there may be differences in the IBD profile of the children from these regions. Therefore, the objective of this study was to investigate the regional variability of Pediatric CD and UC profile in the KSA.

MATERIALS AND METHODS
=====================

Patients population
-------------------

The national multicenter pediatric IBD research project was a retrospective descriptive study of children from birth to 17 years of age with confirmed diagnosis of IBD (CD, UC, IBD-U) from 17 medical centers located mainly in the CR, WR, and ER of the KSA. The diagnosis of CD and UC was confirmed based on clinical, laboratory, imaging, endoscopic, and histopathologic findings in accordance to standard guidelines\[[@B18]\]. All children were diagnosed and managed by gastroenterologists. The CR is represented by the greater Riyadh region, the WR is represented by the Makkah region, including Makkah, Jeddah and Taif cities, and the ER includes Dammam, Al Hasa, Al Khobar, Dhahran, Qatif, and Jubail cities. Two age groups were analyzed; the denominator data of the first group, birth to 14 years of age, were available and were analyzed for incidence and time trend. The second group, which included the whole cohort from birth to 17 years of age, was analyzed for demographics, clinical, and laboratory presentations.

Comparison of incidence time trend
----------------------------------

Incidence and time trend were analyzed for the age group from birth to 14 years of age only. This is because, in the KSA, adult gastroenterologists managed most children above 15 years of age and were not part of the national multicenter study. Hence, available data from patients above 15 years could not be analyzed for incidence and time trend; however, they were added to those below 15 years to form a cohort from birth to 17 years suitable for the analysis of demographic, clinical, and laboratory presentation. We used the officially published census reports of the Central Department of Statistics and Information denominators for incidence calculations\[[@B19]\]. To investigate the incidence time trend, the yearly incidence of CD and UC in each region were calculated and compared to each other. In addition to this, the incidence trend was evaluated for each region using two intervals: interval 1 (2003-2007) and interval 2 (2008-2012).

Demographics and clinical presentation
--------------------------------------

In the cohort of children from birth to 17 years of age, demographic features including gender distribution, family history of IBD, consanguinity, duration of illness, age at diagnosis, and diagnostic delay were analyzed. The clinical presentation and selected laboratory markers of severity were compared between regions. These included the proportion of children presenting with weight loss, abdominal pain, diarrhea, blood in stools, complicated presentation in CD (fistulae, strictures), and pancolitis in UC. Laboratory markers included anemia, low albumin, high erythrocyte sedimentation rate, and high C-reactive protein.

Statistical analysis
--------------------

Data were analyzed using Statistical Package for Social Studies (SPSS 22; IBM Corp., New York, NY, United States). Categorical variables were expressed as percentages. Chi square test and Fisher exact test were used for categorical variables. Generalized linear Poisson Regression model was used to assess the changes in the incidence rates of UC and CD cases by adjusting region (CR, WR, and ER) and using time period (2003-2012) as the offset variable. A *P* \< 0.05 was considered statistically significant.

The statistical methods of this study were reviewed by Ahmad H. Al sharqawi, Biostatistician, Investigator Support Unit, Prince Naif Health Research Center, King Saud University, Kingdom of Saudi Arabia.

Ethical consideration
---------------------

The study is part of the Multicenter Saudi National Pediatric IBD research project approved by the Institutional Review Board of the College of Medicine (No. 10/2647/IRB), King Saud University, Riyadh, Kingdom of Saudi Arabia.

RESULTS
=======

Demographic comparison
----------------------

From January 2003 to December 2012, a total number of 459 IBD cases from birth to 17 years (309 CD, 147 UC, 3 IBD-U) were diagnosed. However, because of small numbers, the IBD-U cases were not included in this analysis. The remaining 456 were distributed according to regions: CR 226 (156 CD, 70 UC), WR 134 (80 CD, 54 UC), and ER 96 (73 CD, 23 UC).

The main demographic comparative features are shown in Table [1](#T1){ref-type="table"}, indicating a higher number of males with CD and UC from the CR and ER, respectively. The prevalence of positive family history was lower in children with CD from the ER than from the CR or the WR; however, there was no difference in children with UC between the regions. Consanguinity rate was higher in children with CD and UC from the CR and the ER, respectively. The children diagnosed with CD and UC from the ER were characterized by a shorter duration of symptoms before presentation, younger age at diagnosis, and shorter diagnostic delay compared to those diagnosed in the CR or the WR.

###### 

Demographics of 456 children from birth to 17 years of age

  **Parameters**                         **Crohn's disease**   **Ulcerative colitis**                                         
  -------------------------------------- --------------------- ------------------------ ------------ ------------ ----------- -----------
  Number of patients                     156                   80                       73           70           54          73
  Gender, % males                        94.6                  44.6                     37.6         39.6         21.4        17.7
  Family history, % positive             17.5                  16.2                     13.9         9.2          9.3         9.5
  Consanguinity, % positive              47                    31.2                     33.8         41.9         24.1        52.6
  Duration of symptoms (mo): mean ± SD   17.5 ± 21.8           10.8 ± 9.9               7.8 ± 9.2    8.7 ± 10.1   5.8 ± 3.9   4.5 ± 3.0
  Age at diagnosis (yr): mean ± SD       14.3 ± 3.5            10.0 ± 4.7               12.3 ± 3.4   9.6 ± 5.0    8.9 ± 4.3   9.0 ± 3.9
  Diagnostic delay (mo): Median (IQR)    12 (4-25)             6 (4-12)                 6 (3-6)      5 (2-9)      6 (3-9)     3 (2-6)

SD: Standard deviation; IQR: Interquartile range.

Incidence time trend
--------------------

There were 390 children from birth to 14 years of age diagnosed with IBD in the three regions. Fifty-five non-Saudi nationals were excluded from the analysis because of the unavailability of denominator data, while two patients were excluded because of the missing data. The remaining 333 Saudi children constituted the study cohort: The CR 39.6% (132/333), the WR 36.4% (121/333), and the ER 24% (80/333).

Comparison of the annual mean incidence of UC and CD in the three regions is shown in Figures [1](#F1){ref-type="fig"}, showing an increasing trend in all regions with no significant difference between them. Comparison of the prevalence trends of two periods (2003-2007 and 2008-2012) between regions presented in Table [2](#T2){ref-type="table"} showed a high trend; however, it was not statistically significant.

![Incidence pattern and time trend for ulcerative colitis and Crohn's disease from 2003 to 2012. A: Incidence pattern and time trend for ulcerative colitis from 2003 to 2012. Although not statistically significant, there is increasing trend in all regions; B: Incidence pattern and time trend for Crohn's disease from 2003 to 2012. Although not statistically significant, there is increasing trend in all regions.](WJG-26-416-g001){#F1}

###### 

Incidence rate trend for ulcerative colitis and Crohn's disease by region

  **Parameters/time periods**   **Incidence rates (95%)/100000**   
  ----------------------------- ---------------------------------- ------------------
  Ulcerative colitis                                               
  Central region                0.27 (0.17-0.41)                   0.37 (0.25-0.52)
  Western region                0.24 (0.14-0.38)                   0.38 (0.26-0.54)
  Eastern region                0.13 (0.05-0.27)                   0.27 (0.16-0.44)
  Crohn's disease                                                  
  Central region                0.32 (0.21-0.48)                   0.37 (0.25-0.52)
  Western region                0.38 (0.25-55)                     0.46 (0.33-0.63)
  Eastern region                0.23 (0.12-0.40)                   0.70 (0.50-0.95)

Clinical presentation
---------------------

Clinical presentation in children with CD is shown in Table [3](#T3){ref-type="table"}. This indicates that a significantly higher proportion of children presented with abdominal pain (*P* = 0.005), complications such as fistula or stenosis (*P* = 0.029), higher anemia (*P* = 0.003), higher erythrocyte sedimentation rate (*P* \< 0.001), higher C-reactive protein (*P* \< 0.001), less blood in stools (*P* = 0.048), and lower albumin levels (*P* = 0.014) in the ER. For children with UC, clinical and laboratory features are presented in Table [4](#T4){ref-type="table"}, indicating a significantly higher percentage of children in the WR presented with diarrhea (*P* = 0.033), whereas a significantly lower percentage of children in the ER presented with pancolitis (*P* \< 0.001), and a higher percentage presented with anemia (*P* = 0.006).

###### 

Presenting features in children with Crohn's disease

  **Parameters**             **Central, %**   **Western, %**   **Eastern, %**   ***P* value**
  -------------------------- ---------------- ---------------- ---------------- ------------------------------------------
  Weight loss                41.5             31.4             43.5             0.467
  Abdominal pain             87.8             75               94.3             0.005[a](#T3FN1){ref-type="table-fn"}
  Diarrhea                   68.9             75               71.7             0.723
  Blood in stool             39.2             29.4             18.9             0.048[a](#T3FN1){ref-type="table-fn"}
  Complicated presentation   22.2             20.3             40.4             0.029[a](#T3FN1){ref-type="table-fn"}
  High CRP                   52               84.3             97.1             \< 0.001[a](#T3FN1){ref-type="table-fn"}
  High ESR                   65.6             63               91.7             \< 0.001[a](#T3FN1){ref-type="table-fn"}
  Low serum albumin          58.3             72.4             87               0.014[a](#T3FN1){ref-type="table-fn"}
  Anemia                     46.3             54.7             77.6             0.003[a](#T3FN1){ref-type="table-fn"}

*P* \< 0.05, it means the significant. CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate.

###### 

Presenting features in children with ulcerative colitis

  **Parameters**               **Central, %**   **Western, %**   **Eastern, %**   ***P* value**
  ---------------------------- ---------------- ---------------- ---------------- ------------------------------------------
  Weight loss                  41.5             31.4             43.5             0.467
  Abdominal pain               67.9             52.9             73.9             0.139
  Diarrhea                     73.6             92.2             78.3             0.033[a](#T4FN1){ref-type="table-fn"}
  Blood in stool               92.5             96.1             91.3             0.64
  Pancolitis at presentation   67.9             23.5             43.5             \< 0.001[a](#T4FN1){ref-type="table-fn"}
  High CRP                     58.8             71.4             45.5             0.347
  High ESR                     71.4             75               83.3             0.605
  Low serum albumin            48.6             30.4             52.9             0.247
  Anemia                       57.4             55.6             90.9             0.006[a](#T4FN1){ref-type="table-fn"}

*P* \< 0.05, it means the significant. CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate.

DISCUSSION
==========

To our knowledge, this is the first study to describe the regional variation in the characteristics of pediatric IBD from a non-Western population. The hypothesis on the possible variations was based on the differences in culture and environment of the main regions of KSA (CR, WR, ER). Most of the population of the CR is tribal, and the environment is dominated by a desert climate and lifestyle. The WR is located near the Red Sea, with a different coastal climate, and the population is less tribal with a different kind of lifestyle. Similarly, the population of the ER, which is located on the Arabian Gulf, is different from the CR and WR in terms of culture. Dominated by oil production and related petrochemical industry, the environment has a coastal climate, and the lifestyle is different from the WR and CR.

Positive family history and consanguinity are considered indirect indicators of genetic susceptibility. In this study, the higher prevalence of positive family history in children with CD and UC in the ER provided a clue for a genetic risk. However, literature suggests that positive family history of pediatric IBD plays a minimal role among the regions\[[@B20]\]. Similarly, comparison of the relatively constant rate of consanguinity in KSA between 1995 and 2013 and the increasing incidence of CD and UC makes the role of consanguinity highly unlikely\[[@B21],[@B22]\]. A previous report from the same population supported this assumption, suggesting that there is no relationship between consanguinity and pediatric IBD\[[@B23]\].

Though it is not statistically significant, the mean annual incidences of CD and UC were increasing in all regions. These findings are consistent with reports of no regional differences in the prevalence of CD between the Northeast and the South, with a higher prevalence of UC in the South of the United States\[[@B24]\].

The most important finding in the study is the significant differences in clinical and laboratory markers at presentation between regions. Compared with the children from the CR and the WR, children from the ER presented with a more severe and complicated CD, a finding that confirms the general impression of some gastroenterologists from the ER (personal communication). The causes of severe CD in the ER were not clear. Late presentation and late diagnosis are unlikely because of the shorter duration of symptoms and shorter diagnostic delay in children from the ER. The ethnic/racial role in the varying profiles of IBD has been reported from different countries emphasizing differences in the incidences and phenotypes between the Blacks, the Hispanics, and the Asians from the United States\[[@B24]\]; between the non-Hispanic Whites, the US-born Hispanics, and the foreign-born Hispanics in the United States\[[@B25]\]; between the Arabs and the Jewish children\[[@B26]\]; and between the Southern Asians living in North West London\[[@B27]\]. However, ethnic/racial factors are unlikely the causes in this relatively homogenous population among all the regions of KSA; instead, it is more likely due to the environmental factors, particularly the lifestyle and microbiota, in the ER.

Limitation of the study
-----------------------

The most important limitation was the retrospective data collection. As a result of this, we were not able to address more specific markers of severity such as documentation the pediatric activity indices over the course of the illness, use of immuno-suppressants or biological agents, the number of hospitalizations, and the need for surgical interventions; instead, we used indirect clinical and laboratory measures of severity in the three regions.

In this study, the most prominent finding is the severe presentation of CD in the Eastern region of the KSA. Regional exploration of IBD profiles within countries may reveal significant differences, which indicates the need for prospective studies that focus on environmental factors, specifically in the form of dietary lifestyle and microbiota analysis. The result of such studies may increase our understanding of IBD.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Inflammatory bowel disease (IBD) has been reported most commonly in Western populations and rarely in others. Increasing reports from developing countries including the Kingdom of Saudi Arabia (KSA) attracted global interest in the search of factors implicated in the pathogenesis of IBD. The present report, exploring IBD profile in different regions may reveal important regional variations undetectable in global national studies.

Research motivation
-------------------

Although increasing incidence trend of Pediatric IBD is well known in the KSA, regional variation in culture and lifestyle may be involved in variation of IBD profile. The result may direct further research to clarify the causes of regional variation.

Research objectives
-------------------

The main objective of this report was to explore regional variations in the profile of pediatric IBD in the KSA. The finding of significantly more severe Crohn's disease (CD) presentation in children from the Eastern region indicates the need for prospective studies to uncover the causes of this variation from the other regions. The results of such studies may increase our understanding of the pathogenesis of IBD.

Research methods
----------------

Data from a national multicenter study of pediatric IBD were used. The incidence, time trend, and clinical presentation of CD and ulcerative colitis (UC) in the Central, Western, and Eastern regions of the KSA were analyzed, and regional comparison was performed. Poisson regression analysis was used to assess regional incidence and Chi-square test for demographic and clinical parameters. A *P* \< 0.05 was considered significant.

Research results
----------------

We found increasing incidence trend of pediatric UC and CD in all regions of the KSA. However, comparison with other regions, children with CD from the ER presented with significantly higher prevalence of complications such as fistula or stenosis, higher anemia, erythrocyte sedimentation rate, and C-reactive protein; as well as less blood in stools and lower albumin levels. The causes of this finding of more disease presentation of CD remains to be studied.

Research conclusions
--------------------

In this study, the more severe clinical profile of CD in children from the ER of the KSA is a new finding. We hypothesize that lifestyle and microbiota variation are potential causes. Regional analysis is recommended as it may reveal significant variations undetectable by overall national studies. Prospective studies focusing on environmental factors are needed to search the cause. Identification of factors implicated in the severe clinical presentation in CD may lead to preventive and therapeutic recommendations.

Research perspectives
---------------------

This study revealed significantly more severe clinical presentation of CD in one of the regions (ER) of the KSA. This finding indicates the need for prospective studies to search the causes of this clinical picture.
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